158 related articles for article (PubMed ID: 25275044)
1. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
[TBL] [Abstract][Full Text] [Related]
2. Significant Association of Cyclo-oxygenase 2 Genotypes with Upper Tract Urothelial Cancer.
Chang WS; Liao CH; Hsu CM; Huang CY; Fang HY; Kao PY; Tsai CW; Wu HC; Hu PS; Wang TC; Syu YR; Shui HA; Bau DT
Anticancer Res; 2015 May; 35(5):2725-30. PubMed ID: 25964551
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the contribution of cyclooxygenase 2 genotypes to breast cancer in Taiwan.
Su CH; Hsiao CL; Chang WS; Liu LC; Wang HC; Tsai CW; Li LY; Tsai CH; Bau DT
Anticancer Res; 2014 Nov; 34(11):6711-6. PubMed ID: 25368279
[TBL] [Abstract][Full Text] [Related]
4. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.
Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y
Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295
[TBL] [Abstract][Full Text] [Related]
5. The Role of IL-10 Promoter Polymorphisms in Renal Cell Carcinoma.
Chang WS; Liao CH; Tsai CW; Hu PS; Wu HC; Hsu SW; Ji HX; Hsiao CL; Bau DT
Anticancer Res; 2016 May; 36(5):2205-9. PubMed ID: 27127124
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.
Obara W; Suzuki Y; Kato K; Tanji S; Konda R; Fujioka T
Int J Urol; 2007 Jun; 14(6):483-7. PubMed ID: 17593089
[TBL] [Abstract][Full Text] [Related]
7. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
8. The role of XRCC6 T-991C functional polymorphism in renal cell carcinoma.
Chang WS; Ke HL; Tsai CW; Lien CS; Liao WL; Lin HH; Lee MH; Wu HC; Chang CH; Chen CC; Lee HZ; Bau DT
Anticancer Res; 2012 Sep; 32(9):3855-60. PubMed ID: 22993329
[TBL] [Abstract][Full Text] [Related]
9. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
10. Glutathione S-transferase M1, T1, and P1 polymorphisms as risk factors for renal cell carcinoma: a case-control study.
Sweeney C; Farrow DC; Schwartz SM; Eaton DL; Checkoway H; Vaughan TL
Cancer Epidemiol Biomarkers Prev; 2000 Apr; 9(4):449-54. PubMed ID: 10794492
[TBL] [Abstract][Full Text] [Related]
11. Association of caveolin-1 genotypes with renal cell carcinoma risk in Taiwan.
Chang WS; Tsai CW; Wang SM; Wang SW; Wu HC; Ji HX; Lin CH; Wang ZH; Chou JC; Bau DT; Wang PS
Chin J Physiol; 2014 Aug; 57(4):220-6. PubMed ID: 25246063
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer.
Tanaka Y; Hirata H; Chen Z; Kikuno N; Kawamoto K; Majid S; Tokizane T; Urakami S; Shiina H; Nakajima K; Dhir R; Dahiya R
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):92-7. PubMed ID: 17220335
[TBL] [Abstract][Full Text] [Related]
13. Association study of cyclooxygenase 2 single nucleotide polymorphisms and childhood acute lymphoblastic leukemia in Taiwan.
Wang CH; Wu KH; Yang YL; Peng CT; Wang RF; Tsai CW; Tsai RY; Lin DT; Tsai FJ; Bau DT
Anticancer Res; 2010 Sep; 30(9):3649-53. PubMed ID: 20944149
[TBL] [Abstract][Full Text] [Related]
14. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
Safarinejad MR; Shafiei N; Safarinejad S
Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
[TBL] [Abstract][Full Text] [Related]
15. [Cyclooxygenase 2 genetic variant interacting with tobacco smoking and the risk of lung cancer].
Zhang Z; Liu R; Yang ZH; Wang GX; Shao SS; Song QQ; Zhang XM
Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Aug; 47(8):736-40. PubMed ID: 24246081
[TBL] [Abstract][Full Text] [Related]
16. The CASP8 -652 6N insertion/deletion promoter polymorphism is associated with renal cell carcinoma risk and metastasis.
de Martino M; Haitel A; Schatzl G; Klingler HC; Klatte T
J Urol; 2013 Aug; 190(2):717-22. PubMed ID: 23313206
[TBL] [Abstract][Full Text] [Related]
17. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer.
Cozar JM; Romero JM; Aptsiauri N; Vazquez F; Vilchez JR; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2007 Aug; 68(8):698-704. PubMed ID: 17678726
[TBL] [Abstract][Full Text] [Related]
18. Effect of a functional polymorphism in the pre-miR-146a gene on the risk and prognosis of renal cell carcinoma.
Huang Z; Lu Z; Tian J; Wang G; Gao Z
Mol Med Rep; 2015 Nov; 12(5):6997-7004. PubMed ID: 26323945
[TBL] [Abstract][Full Text] [Related]
19. A functional insertion/deletion polymorphism (-94 ins/del ATTG) in the promoter region of the NFKB1 gene is related to the risk of renal cell carcinoma.
Cai H; Sun L; Cui L; Cao Q; Qin C; Zhang G; Mao X; Wang M; Zhang Z; Shao P; Yin C
Urol Int; 2013; 91(2):206-12. PubMed ID: 23295440
[TBL] [Abstract][Full Text] [Related]
20. Association of COX2 functional polymorphisms and the risk of vitiligo in Chinese populations.
Li M; Gao Y; Li C; Liu L; Li K; Gao L; Wang G; Zhang Z; Gao T
J Dermatol Sci; 2009 Mar; 53(3):176-81. PubMed ID: 19004621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
